NVIDIA
NVDA
Tesla
TSLA
Super Micro Computer
SMCI
4
Palantir
PLTR
5
Hims & Hers Health
HIMS
US Stock MarketDetailed Quotes
FULC Fulcrum Therapeutics
- 3.700
- 0.0000.00%
Close Feb 25 16:00 ET
- 3.700
- 0.0000.00%
Post 20:01 ET
199.72MMarket Cap-23.13P/E (TTM)
3.800High3.360Low444.58KVolume3.580Open3.700Pre Close1.64MTurnover1.68%Turnover RatioLossP/E (Static)53.98MShares13.70052wk High0.82P/B98.06MFloat Cap2.86052wk Low--Dividend TTM26.50MShs Float33.098Historical High--Div YieldTTM11.89%Amplitude2.250Historical Low3.689Avg Price1Lot Size
Fulcrum Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 2,752.05%80M | 0 | 0 | 8,990.91%80M | 0 | -55.77%2.81M | 27.15%871K | -35.84%759K | -53.24%880K | -88.62%295K |
| Operating revenue | 2,752.05%80M | --0 | --0 | 8,990.91%80M | --0 | -55.77%2.81M | 27.15%871K | -35.84%759K | -53.24%880K | -88.62%295K |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -12.02%99.83M | -32.69%19.43M | -18.21%23.06M | -2.36%27.51M | 5.66%29.83M | -4.23%113.47M | 0.58%28.86M | 12.47%28.2M | -22.00%28.17M | -1.24%28.24M |
| Selling and administrative expenses | -12.53%36.45M | -21.78%7.72M | -15.43%8.42M | -0.74%10.25M | -12.66%10.06M | -0.06%41.67M | -2.63%9.86M | 2.62%9.96M | -6.98%10.32M | 7.07%11.52M |
| -General and administrative expense | -12.53%36.45M | -21.78%7.72M | -15.43%8.42M | -0.74%10.25M | -12.66%10.06M | -0.06%41.67M | -2.63%9.86M | 2.62%9.96M | -6.98%10.32M | 7.07%11.52M |
| Research and development costs | -11.72%63.39M | -38.35%11.71M | -19.73%14.64M | -3.29%17.26M | 18.29%19.77M | -6.49%71.8M | 2.33%19M | 18.69%18.24M | -28.66%17.85M | -6.26%16.72M |
| Operating profit | 82.08%-19.83M | 30.59%-19.43M | 15.95%-23.06M | 292.33%52.49M | -6.78%-29.83M | 1.31%-110.66M | 0.07%-27.99M | -14.86%-27.44M | 20.28%-27.29M | -7.47%-27.94M |
| Net non-operating interest income expense | ||||||||||
| Other net income (expense) | -24.16%10.11M | -11.59%2.86M | -60.06%1.37M | -16.87%2.92M | -6.23%2.96M | 489.00%13.33M | 72.49%3.24M | 2,151.97%3.42M | 2,026.67%3.51M | 4,415.71%3.16M |
| Special income (charges) | ---2.06M | --0 | ---2.06M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| -Less：Restructuring and merger&acquisition | --2.06M | --0 | --2.06M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Other non- operating income (expenses) | -8.68%12.17M | -11.59%2.86M | 0.20%3.43M | -16.87%2.92M | -6.23%2.96M | 395.50%13.33M | 76.06%3.24M | 454.78%3.42M | 2,026.67%3.51M | 4,415.71%3.16M |
| Income before tax | 90.01%-9.73M | 33.07%-16.57M | 9.66%-21.7M | 332.98%55.41M | -8.44%-26.87M | 11.41%-97.34M | 5.28%-24.76M | -1.18%-24.02M | 30.19%-23.78M | 4.43%-24.78M |
| Income tax | ||||||||||
| Net income | 90.01%-9.73M | 33.07%-16.57M | 9.66%-21.7M | 332.98%55.41M | -8.44%-26.87M | 11.41%-97.34M | 5.28%-24.76M | -1.18%-24.02M | 30.19%-23.78M | 4.43%-24.78M |
| Net income continuous Operations | 90.01%-9.73M | 33.07%-16.57M | 9.66%-21.7M | 332.98%55.41M | -8.44%-26.87M | 11.41%-97.34M | 5.28%-24.76M | -1.18%-24.02M | 30.19%-23.78M | 4.43%-24.78M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 90.01%-9.73M | 33.07%-16.57M | 9.66%-21.7M | 332.98%55.41M | -8.44%-26.87M | 11.41%-97.34M | 5.28%-24.76M | -1.18%-24.02M | 30.19%-23.78M | 4.43%-24.78M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 90.01%-9.73M | 33.07%-16.57M | 9.66%-21.7M | 332.98%55.41M | -8.44%-26.87M | 11.41%-97.34M | 5.28%-24.76M | -1.18%-24.02M | 30.19%-23.78M | 4.43%-24.78M |
| Basic earnings per share | 89.94%-0.16 | 22.50%-0.31 | 10.26%-0.35 | 334.21%0.89 | -4.88%-0.43 | 34.84%-1.59 | 20.00%-0.4 | 23.53%-0.39 | 54.22%-0.38 | 35.94%-0.41 |
| Diluted earnings per share | 89.94%-0.16 | 22.50%-0.31 | 10.26%-0.35 | 328.95%0.87 | -4.88%-0.43 | 34.84%-1.59 | 20.00%-0.4 | 23.53%-0.39 | 54.22%-0.38 | 35.94%-0.41 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |